Novel polynucleotide and method for producing l-alanine using same
Patent Information
- Application Number
- MYPI2025002494
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-12-30
- Filing Date
- 2023-12-12
- Publication Date
- 2024-06-30
AI Technical Summary
Current methods for producing L-alanine, such as chemical synthesis, are not aligned with consumer preferences for natural products, and there is a need for more efficient production methods to meet increasing demand.
A novel polynucleotide with specific mutations in the promoter region of the alaT gene is used to enhance the production capacity of L-alanine in host cells, specifically by substituting nucleotides at positions 88, 90, and 91, which increases promoter activity and amino acid production.
The modified polynucleotide significantly increases L-alanine production capacity in host cells, demonstrated by a 142% increase in L-alanine concentration compared to the parent strain, making it a more efficient method for producing high concentrations of L-alanine.
Abstract
Description
Novel polynucleotide and method for producing L-alanine using the same
[0001] Cross-citation with related application(s)
[0002] This application claims the benefit of priority to Korean Patent Application No. 10-2022-0190977, filed December 30, 2022, the entire contents of which are incorporated herein by reference.
[0003] The present invention relates to a novel polynucleotide and a method for producing L-alanine using the same, and more particularly, to a novel polynucleotide, a recombinant vector containing the polynucleotide, a host cell transformed with the vector, and a method for producing L-alanine using the host cell.
[0004]
[0005] L-Alanine is a colorless or white crystalline amino acid with no odor but a distinctive sweet flavor. It has a wide range of applications in the chemical, food, and pharmaceutical industries. In the food industry, it is particularly effective as a flavor enhancer or nutritional fortifier, enhancing savory flavor and exhibiting various physiological effects, including promoting alcohol metabolism, protecting liver function, and stimulating insulin secretion. Compared to other amino acids, it inhibits browning, making it a preferred acidity corrector. It is also widely utilized in various fields, including as a medicine for benign prostatic hyperplasia and in sports products. As of 2020, the annual production of alanine was approximately 500 tons, and its market size was estimated to exceed USD 250 million.
[0006] Most food additives or color additives are obtained through natural resource extraction, chemical synthesis, or biological production. L-alanine is primarily produced through chemical synthesis or enzymatic conversion. With consumers' awareness of a healthy lifestyle shifting, natural products have become more preferred over synthetic alternatives, despite their higher price due to lower production volumes. Consequently, various research efforts are underway to develop methods for producing L-alanine beyond petroleum-derived sources, such as developing high-concentration amino acid-producing microorganisms or fermentation processes.
[0007] A common method for producing L-alanine is fermentation using microorganisms such as Corynebacterium, Escherichia coli, Brevibacterium, and Lactobacillus (US 5559016 A).
[0008] However, with the increasing demand for L-alanine, there is a growing need for research to produce high concentrations of L-alanine more efficiently.
[0009] Accordingly, the inventors of the present invention have made efforts to develop a microorganism capable of producing high concentrations of L-alanine, and as a result, have developed a novel polynucleotide in which a specific position of the promoter region of the gene encoding alaT is mutated, and have confirmed that the production amount of L-alanine can be improved using the polynucleotide, thereby completing the present invention.
[0010]
[0011] One example of the present invention provides a polynucleotide in which the nucleotides corresponding to the 88th and 90th positions are each substituted with T, and the nucleotide corresponding to the 91st position is substituted with A, based on the nucleotide sequence represented by SEQ ID NO: 2.
[0012] Another example of the present invention provides a vector comprising the polynucleotide and a gene encoding a target protein operably linked to the polynucleotide.
[0013] Another example of the present invention provides a host cell comprising the polynucleotide and a gene encoding a target protein operably linked to the polynucleotide.
[0014] Another example of the present invention provides a method for producing an amino acid comprising the step of culturing the host cell in a medium.
[0015] Another example of the present invention provides a composition for producing amino acids comprising the host cell.
[0016] Another example of the present invention provides a polynucleotide, wherein the nucleotides corresponding to the 88th and 90th positions are each substituted with T and the nucleotide corresponding to the 91st position is substituted with A, based on the nucleotide sequence represented by SEQ ID NO: 2, a vector comprising the polynucleotide, and a use for producing amino acids in a host cell comprising the vector.
[0017]
[0018] This is specifically explained as follows. Meanwhile, each description and embodiment disclosed in the present invention can also be applied to each other description and embodiment. In other words, all combinations of the various elements disclosed in the present invention fall within the scope of the present invention. Furthermore, the scope of the present application is not limited by the specific descriptions described below.
[0019]
[0020] The present invention provides a polynucleotide in which the nucleotides corresponding to the 88th and 90th positions are each substituted with T, and the nucleotide corresponding to the 91st position is substituted with A, based on the nucleotide sequence represented by SEQ ID NO: 2.
[0021] In this specification, the term “nucleotide sequence represented by SEQ ID NO: 2” may mean a part of a promoter sequence of a gene encoding an aminotransferase.
[0022] The term "aminotransferase" herein may be used interchangeably with "aminotransferase" and refers to an enzyme capable of reversibly producing L-alanine from pyruvate. The cofactor L-valine used in this process may contribute to the reduction of byproducts.
[0023] In this specification, the term “L-alanine” refers to an L-amino acid having the chemical formula HO2CCH(NH2)CH3, which is one of the essential amino acids.
[0024] The above polynucleotide may have promoter activity.
[0025] As used herein, the term “promoter” refers to a DNA region upstream of a coding region that includes a binding site for polymerase and has transcription initiation activity into mRNA of a target gene of the promoter, i.e., a DNA region to which a polymerase binds to initiate transcription of the gene. The promoter may be located at the 5' end of the mRNA transcription initiation site. In this case, the target gene of the promoter may be, but is not limited to, a gene encoding an aminotransferase.
[0026] The polynucleotide of the present invention is a nucleotide sequence represented by the above SEQ ID NO: 2, that is, a part of the promoter sequence of a gene encoding an aminotransferase, which is mutated. Specifically, the mutation may be such that the nucleotides corresponding to the 88th and 90th positions of the above sequence are each substituted with T, and the nucleotide corresponding to the 91st position is substituted with A. Accordingly, the polynucleotide may consist of the nucleotide sequence of the above SEQ ID NO: 1.
[0027] The above term “mutation” means a genetically or non-genetically stable phenotypic change, and may be used interchangeably with “mutation” in this specification.
[0028] Specifically, the polynucleotide may have increased promoter activity compared to a polynucleotide that does not contain the mutation (a wild-type polynucleotide). Accordingly, the polynucleotide may regulate (increase) the expression of a target gene operably linked to the polynucleotide and the activity of a protein encoded by the target gene, and further, may regulate the expression of genes other than the target gene.
[0029] The polynucleotide may be introduced into a suitable host cell and have an activity that increases the amino acid production capacity (production amount) of the host cell, for example, the production capacity (production amount) of L-alanine. Accordingly, the polynucleotide may be for increasing the production capacity (production amount) of amino acids, and specifically, for increasing the production capacity (production amount) of L-alanine.
[0030] Specifically, the polynucleotide may be composed of a nucleotide sequence of sequence number 1.
[0031] In addition, the nucleotide sequence of the present invention can be modified by conventionally known mutagenesis methods, such as directed evolution and site-directed mutagenesis.
[0032] Accordingly, the polynucleotide may include a polynucleotide comprising a nucleotide sequence having at least 60% homology to the nucleotide sequence of SEQ ID NO: 1, specifically 70% homology to the nucleotide sequence of SEQ ID NO: 1, specifically 80% homology to the nucleotide sequence of SEQ ID NO: 1, specifically 83% homology to the nucleotide sequence of SEQ ID NO: 1, specifically 84% homology to the nucleotide sequence of SEQ ID NO: 1, specifically 8 ...
[0033] As used herein, the term "identity or homology" refers to the degree of identity with a given nucleic acid sequence or amino acid sequence, and can be expressed as a percentage (%). For nucleic acid sequence homology, for example, it can be determined using the algorithm BLAST by the literature (see: Karlin and Altschul, Pro. Natl. Acad. Sci. USA, 90, 5873, 1993) or FASTA by Pearson (see: Methods Enzymol., 183, 63, 1990). Based on the algorithm BLAST, programs called BLASTN and BLASTX have been developed (see: http: / www.ncbi.nlm.nih.gov).
[0034] In one example, a polynucleotide comprising a specific nucleic acid sequence provided herein may be interpreted to include not only the specific nucleic acid sequence or a nucleic acid sequence substantially equivalent thereto, but also a polynucleotide fragment comprising a nucleic acid sequence complementary to the specific nucleic acid sequence. Specifically, the polynucleotide having the complementarity can be hybridized at a Tm value that can be appropriately adjusted by one skilled in the art depending on the purpose, for example, a Tm value of 55°C, 60°C, 63°C, or 65°C, and analyzed under the conditions described below: such conditions are specifically described in known literature. For example, conditions in which genes with high complementarity of 60% or more, 70% or more, 80% or more, 85% or more, 90% or more, 91% or more, 92% or more, 93% or more, 94% or more, 95% or more, 96% or more, 97% or more, 98% or more, 98% or more, 99.5% or more, or 99.9% or more hybridize, and genes with lower complementarity do not hybridize, or washing conditions of conventional Southern hybridization: 60°C, 1x SSC (saline-sodium citrate buffer), and 0.1% (w / v) SDS (Sodium Dodecyl Sulfate); 60°C, 0.1x SSC, and 0.1% SDS; Or, conditions such as washing once, specifically two to three times, at a salt concentration and temperature equivalent to 68°C, 0.1x SSC, and 0.1% SDS, etc., can be listed, but are not limited thereto. Hybridization requires that two nucleotides have complementary sequences, or mismatches between bases may be allowed depending on the stringency of hybridization. The term "complementary" can be used to describe the relationship between nucleotide bases that can hybridize with each other. For example, in the case of DNA, adenosine is complementary to thymine, and cytosine is complementary to guanine.The appropriate stringency for hybridizing polynucleotides depends on the length and degree of complementarity of the polynucleotides, and is well known in the art (see Sambrook et al., supra, 9.50-9.51, 11.7-11.8).
[0035] In particular, the expression “consist of the nucleotide sequence of SEQ ID NO: 1” does not exclude cases in which addition, deletion, and / or mutation of nucleotides may occur during the process of linking to the target gene, such as using a restriction enzyme, when the polynucleotide is used as a promoter by linking to the target gene.
[0036] For example, the polynucleotide having biological activity (promoter activity) and / or a desired activity (e.g., increasing L-alanine production in a host cell) consisting of a nucleotide sequence represented by SEQ ID NO: 1 may include, without limitation, a nucleotide sequence that hybridizes under stringent conditions with a complementary sequence for all or part of the nucleotide sequence of SEQ ID NO: 1 and has the biological activity (promoter activity) and / or a desired activity (e.g., increasing L-alanine production in a host cell) of the present application.
[0037] Furthermore, the polynucleotide of the present invention can be operably linked to a gene encoding a target protein.
[0038] As used herein, the term “gene expression control sequence” refers to a sequence capable of expressing a target gene operably linked to the polynucleotide of the present invention.
[0039] As used herein, the term "operably linked" means that a polynucleotide having promoter activity of the present invention is functionally linked to a gene sequence to initiate and mediate transcription of the target gene. Operable linkages can be produced using genetic recombination techniques known in the art, and site-specific DNA cleavage and ligation can be produced using cleavage and ligation enzymes known in the art, but are not limited thereto.
[0040] Furthermore, the gene expression control sequence of the present invention may further include, in addition to a promoter for carrying out transcription of a gene, an arbitrary operator sequence for controlling transcription, a sequence encoding a suitable mRNA ribosome binding site, and DNA for controlling termination of transcription and translation.
[0041] For example, a regulatory sequence suitable for prokaryotes may include, but is not limited to, a ribosome binding site in addition to a promoter. A polynucleotide having promoter activity of the present invention can be constructed by a person skilled in the art to construct a sequence for regulating gene expression as described above, as needed.
[0042] In the present invention, the target gene refers to a gene encoding a target protein whose expression is to be controlled in a microorganism.
[0043] For example, the gene may be, but is not limited to, a gene involved in amino acid production. Specifically, the gene may be, but is not limited to, a gene encoding an enzyme involved in amino acid biosynthesis. More specifically, the gene may be, but is not limited to, a gene encoding an aminotransferase.
[0044]
[0045] In addition, the present invention provides a vector including a polynucleotide in which the nucleotides corresponding to the 88th and 90th positions are each substituted with T, and the nucleotide corresponding to the 91st position is substituted with A, based on the nucleotide sequence represented by SEQ ID NO: 2.
[0046] The above polynucleotide is as described above.
[0047] The above vector may further comprise a gene encoding a target protein operably linked to the above polynucleotide.
[0048] As used herein, the term "vector" refers to a DNA construct containing a base sequence of a polynucleotide encoding a target protein operably linked to suitable regulatory sequences so as to enable expression of the target protein in a suitable host. The regulatory sequences may include a promoter capable of initiating transcription, an optional operator sequence for regulating transcription, a sequence encoding a suitable mRNA ribosome binding site, and / or a sequence regulating the termination of transcription and / or translation. After being transformed into a suitable host cell, the vector may be expressed independently of the genome (genetics) of the host cell, or may be integrated into the genome of the host cell.
[0049] The vector usable in this specification is not particularly limited as long as it is replicable in a host cell, and may be selected from all commonly used vectors. Examples of commonly used vectors include plasmids, cosmids, viruses, bacteriophages, etc. in a natural or recombinant state. For example, as the vector, pWE15, M13, MBL3, MBL4, IXII, ASHII, APII, t10, t11, Charon4A, and Charon21A, etc. can be used as a phage vector or a cosmid vector, and pDZ series, pBR series, pUC series, pBluescriptII series, pGEM series, pTZ series, pCL series, and pET series, etc. can be used as a plasmid vector. Specifically, examples include, but are not limited to, pDZ, pACYC177, pACYC184, pCL, pECCG117, pUC19, pBR322, pMW118, and pCC1BAC vectors.
[0050] The vector usable herein may be a known expression vector and / or a vector for insertion of a polynucleotide into a host cell chromosome. The insertion of the polynucleotide into the host cell chromosome may be accomplished by any method known in the art, such as, but not limited to, homologous recombination or the CRISPR system. The vector may further include a selection marker for confirming whether the polynucleotide has been inserted into the chromosome. The selection marker is used to select cells transformed with the vector, i.e., to confirm whether the polynucleotide has been inserted, and may be selected from among genes that confer a selectable phenotype, such as drug resistance, nutrient requirement, cytotoxic agent resistance, or expression of a surface protein. In an environment treated with a selective agent, only cells expressing the selection marker survive or exhibit other phenotypic traits, thereby allowing the selection of transformed cells.
[0051]
[0052] In addition, the present invention provides a host cell comprising the polynucleotide and a gene encoding a target protein operably linked to the polynucleotide.
[0053] The gene encoding the polynucleotide and the target protein operably linked to the polynucleotide are as described above.
[0054] The above host cell may be, but is not limited to, a microorganism.
[0055] In this specification, the term “microorganism” includes both wild-type microorganisms and microorganisms that have undergone genetic modification, either naturally or artificially, and is a concept that includes all microorganisms whose specific mechanisms have been weakened or strengthened due to causes such as the insertion of external genes or the strengthening or weakening of the activity of endogenous genes.
[0056] In the present invention, the microorganism may comprise the polynucleotide, and specifically, may comprise the polynucleotide and / or a gene operably linked to the polynucleotide and encoding a target protein. Alternatively, the microorganism may comprise a vector comprising the polynucleotide or a gene expression control sequence and a gene encoding the target protein, but is not limited thereto. In addition, the polynucleotide, the gene encoding the target protein, and the vector may be introduced into the microorganism by transformation, but is not limited thereto. Furthermore, as long as the gene can be expressed, the microorganism is independent of whether the polynucleotide and the gene encoding the target protein are located on or outside the chromosome.
[0057] A microorganism comprising the above polynucleotide and a gene encoding a target protein may have increased amino acid production capacity, and specifically, may have increased L-alanine production capacity.
[0058] For example, the microorganism may be enriched in aminotransferase.
[0059] In the present invention, the microorganism may be included without limitation as long as it is a microorganism into which a polynucleotide having the promoter activity of the present invention is introduced and can operate as a promoter.
[0060] For example, the microorganism is a cell or microorganism that is transformed with a vector containing the polynucleotide of the present application and expresses the polynucleotide of the present application. For the purpose of the present application, the microorganism of the present application may include all microorganisms capable of producing L-alanine, including variants of the present application. For example, the microorganism of the present application may be a recombinant strain in which the polynucleotide of the present application is introduced into a natural wild-type microorganism or a microorganism that produces L-alanine, thereby enhancing aminotransferase and increasing L-alanine production ability. The recombinant strain in which L-alanine production ability is increased may be a microorganism in which L-alanine production ability is increased compared to a natural wild-type microorganism or a microorganism in which the promoter region of the gene encoding alaT is not modified (i.e., a microorganism expressing the promoter of the wild-type alaT encoding gene), but is not limited thereto. For example, the target strain for comparing whether the L-alanine production ability is increased, the promoter region of the gene encoding alaT, which is a non-modified microorganism, may be a wild-type Corynebacterium glutamicum strain, and in one specific example, may be a Corynebacterium glutamicum ATCC13869 strain, but is not limited thereto.
[0061] For example, the L-alanine production ability of the microorganism with increased L-alanine production ability may be increased by about 1% or more, about 2.5% or more, about 5% or more, about 10% or more, about 15% or more, about 20% or more, about 25% or more, about 30% or more, about 35% or more, about 36% or more, about 37% or more, about 38% or more, about 39% or more, about 40% or more, about 41% or more, or about 42% or more (the upper limit is not particularly limited and may be, for example, about 200% or less, about 150% or less, about 100% or less, or about 50% or less) compared to the L-alanine production ability (or production ability) of the parent strain or the unmodified microorganism before mutation.
[0062] In another example, the microorganism with increased L-alanine production ability may have an L-alanine production (or production ability) increased by about 1.1 times or more, about 1.12 times or more, about 1.13 times or more, about 1.15 times or more, about 1.16 times or more, about 1.17 times or more, about 1.18 times or more, about 1.19 times or more, about 1.2 times or more, about 1.25 times or more, about 1.3 times or more, about 1.35 times or more, about 1.40 times or more, about 1.41 times or more, or about 1.42 times or more (the upper limit is not particularly limited and may be, for example, about 10 times or less, about 5 times or less, about 3 times or less, or about 2 times or less), but is not limited thereto. The term “about” above includes all ranges including ±0.5, ±0.4, ±0.3, ±0.2, ±0.1, etc., and includes all ranges of values equal to or similar to the value following the term “about,” but is not limited thereto.
[0063] In the present application, the term "unmodified microorganism" does not exclude a strain that contains a mutation that may occur naturally in a microorganism, and may refer to a wild-type strain or a natural strain itself, or a strain before its characteristics are changed by genetic mutation caused by natural or artificial factors. For example, the unmodified microorganism may refer to a strain into which a promoter region mutant polynucleotide of a gene encoding alaT described herein is not introduced or is introduced before it is introduced. The term "unmodified microorganism" may be used interchangeably with "pre-modified strain," "pre-modified microorganism," "unmutated strain," "unmodified microorganism," or "reference microorganism."
[0064] Specifically, the microorganism may be a microorganism of the genus Corynebacterium, and more specifically, may include, but is not limited to, Corynebacterium stationis, Corynebacterium thermoaminogenes, Corynebacterium glutamicum, Brevibacterium flavum, Brevibacterium lactofermentum, and strains prepared therefrom. Specifically, the microorganism may be a strain of Corynebacterium stationis or Corynebacterium glutamicum.
[0065]
[0066] In addition, the present invention provides a method for producing an amino acid, which comprises the step of culturing a host cell containing a polynucleotide in a medium, wherein the nucleotides corresponding to the 88th and 90th positions are each substituted with T and the nucleotide corresponding to the 91st position is substituted with A, based on the nucleotide sequence represented by SEQ ID NO: 2.
[0067] The polynucleotide and host cell are as described above.
[0068] The method may further include, after the culturing step, a step of recovering amino acids from the cultured microorganism, the culture, or both.
[0069] The above amino acid may be, but is not limited to, L-alanine.
[0070] The term “cultivation” as used herein refers to growing microorganisms under appropriately artificially controlled environmental conditions. The method for culturing the microorganisms of the present invention can be performed using a culture method for Corynebacterium glutamicum, which is widely known in the art. Specifically, examples of the culture method include, but are not limited to, batch culture, continuous culture, and fed-batch culture. Various such methods are disclosed, for example, in “Biochemical Engineering” (James M. Lee, Prentice-Hall International Editions, pp. 138-176, 1991).
[0071] The term "culture" as used herein refers to a substance containing a medium in which microorganisms are growing or have completed growth under appropriately artificially controlled environmental conditions. In a narrow sense, the culture does not include grown microorganisms, but in a broader sense, it may include them. The "culture" includes various substances released by the microorganisms into the medium during growth, along with medium components prepared for culturing the microorganisms, and specifically includes the target substance, L-alanine.
[0072] The culture medium must suitably meet the requirements of the specific strain. Culture media for strains of the genus Corynebacterium are known. For example, the microorganism of the present application can be cultured under aerobic conditions, while controlling temperature, pH, etc., in a conventional medium containing an appropriate carbon source, nitrogen source, amino acid, vitamin, etc. In this case, the carbon source includes carbohydrates such as glucose, fructose, and sucrose, and amino acids such as glutamic acid and cysteine. Specifically, natural organic nutrients such as starch hydrolysate and molasses can be used, and carbohydrates such as glucose, fructose, and sterilized pretreated molasses (i.e., molasses converted to reducing sugar) are preferred. Other appropriate carbon sources can be used in various amounts without limitation, but are not limited thereto. Nitrogen sources include inorganic nitrogen sources such as ammonia; amino acids such as glutamic acid and cysteine; and organic nitrogen sources such as peptone, meat extract, and yeast extract. These nitrogen sources can be used alone or in combination, but are not limited thereto. The media may include, but are not limited to, phosphoric acid, potassium dihydrogen phosphate, or dipotassium hydrogen phosphate or their corresponding sodium-containing salts as the personnel. Inorganic compounds may include, but are not limited to, magnesium sulfate, iron sulfate, manganese sulfate, and calcium chloride, and may also include amino acids, vitamins, and appropriate precursors. These media or precursors may be added to the culture in batch or continuous fashion, but are not limited to these.
[0073] During cultivation, compounds such as potassium hydroxide, ammonia, and phosphoric acid can be appropriately added to the culture to adjust the pH of the culture. Furthermore, foaming agents such as fatty acid polyglycol esters can be used to suppress foaming during cultivation. Furthermore, oxygen or an oxygen-containing gas can be injected into the culture to maintain an aerobic state. The culture temperature ranges from 27°C to 37°C, specifically from 30°C to 33°C. The cultivation period can continue until the desired amount of useful substances is obtained, and is typically 20 to 120 hours.
[0074] The step of recovering the amino acid may involve collecting the desired amino acid from a medium, culture solution, or microorganism using any legal method known in the art, depending on the culture method. For example, the step of recovering may be performed using one or more methods selected from, but not limited to, centrifugation, filtration, anion exchange chromatography, crystallization, HPLC, etc. The method of producing the amino acid may additionally include a purification step before, simultaneously with, or after the step of recovering.
[0075]
[0076] The present invention relates to a novel polynucleotide and a method for producing L-alanine using the same. A microorganism into which the novel polynucleotide in which a specific position of the promoter region of a gene encoding alaT of the present invention is mutated has a significantly increased ability to produce L-alanine, and therefore the novel polynucleotide can be usefully utilized for efficiently producing L-alanine.
[0077]
[0078] Hereinafter, the present invention will be described in more detail with reference to the following examples. However, these examples are intended only to illustrate the present invention, and the scope of the present invention is not limited by these examples.
[0079]
[0080] Example 1. Production of a strain with a mutation introduced into the promoter region of the alaT gene.
[0081] An attempt was made to create a mutant strain in which mutations were introduced in which the 88th nucleotide C was substituted with T, the 90th nucleotide A was substituted with T, and the 91st nucleotide C was substituted with A in the promoter sequence of the alaT gene.
[0082] Specifically, in order to introduce the mutation into wild-type Corynebacterium glutamicum (ATCC13869) (substitution of the 88th nucleotide C with T, the 90th nucleotide A with T, and the 91st nucleotide C with A in the promoter region sequence represented by SEQ ID NO: 2), a gene fragment including the mutation was obtained through PCR using each pair of primers of SEQ ID NO: 3 and SEQ ID NO: 4, and SEQ ID NO: 5 and SEQ ID NO: 6. The PCR conditions were denaturation at 95°C for 5 minutes, followed by 30 cycles of denaturation at 95°C for 30 seconds, annealing at 55°C for 30 seconds, and polymerization at 72°C for 30 seconds, and then polymerization at 72°C for 5 minutes. More specifically, a 500 bp polynucleotide amplified using primers of SEQ ID NO: 3 and SEQ ID NO: 4 and a 500 bp polynucleotide amplified using primers of SEQ ID NO: 5 and SEQ ID NO: 6 were obtained. The two obtained gene fragments were ligated to pDCM2 (Republic of Korea Publication No. 10-2020-0136813) digested with restriction enzymes BamHI and SalI using an infusion enzyme to construct a single gene replacement vector containing an alaT promoter mutation, which was named pDCM2-Pm_alaT. The primer sequence information used to construct the above vector is shown in Table 1 below.
[0083] Sequence number Primer name Sequence (5'->3') 3alaT_AFCTCGGTACCCGGGGATCCACAGCCTGGTCGCAGTCC 4alaT_ARGTCTGTAGTCATCCGCTCAATTTTGCCACTTTGTGT 5alaT_BFACACAAAGTGGCAAAATTGAGCGGATGACTACAGACA 6alaT_BRGCATGCCTGCAGGTCGACGTTGGCGATCATGTCACG
[0084] The above vector was transformed into Corynebacterium glutamicum ATCC13869 by the electric pulse method (Appl. Microbiol. Biotechnol., 1999), and colonies were obtained by spreading on a complex plate medium containing 25 mg / L kanamycin. Afterwards, the final strain containing the mutation and removing the introduced vector was obtained through the conventional secondary crossing process. The strain into which the mutation was introduced was finally confirmed through gene sequence analysis using the primer pair of SEQ ID NO: 7 (5'-ACGTCAAAGCCTGTGCATC-3') and SEQ ID NO: 8 (5'- CAGCACGTCCTTCATCTTCTC-3'). The strain into which the target mutation was introduced was named CJ0021.
[0085]
[0086] Example 2. Confirmation of L-alanine production in a strain into which a novel promoter mutant gene has been introduced.
[0087] In order to compare the L-alanine production ability of the mutant strain CJ0021 produced through the above Example 1 and the wild type Corynebacterium glutamicum ATCC 13869 strain, they were cultured using the following method.
[0088] Specifically, the parent strain, Corynebacterium glutamicum ATCC13869, and the mutant strain CJ0021 were each inoculated into a 250 mm corner-baffle flask containing 25 ml of production medium, and then cultured at 30°C for 46 hours at 200 rpm.
[0089] After the culture was completed, the concentration of L-alanine in each medium was measured using liquid high-performance chromatography, and the concentration of L-alanine in the culture medium for each strain tested is shown in Table 2 below.
[0090] Comparison of L-alanine production between Corynebacterium glutamicum ATCC13869 and Corynebacterium glutamicum CJ0021 strains. ATCC13869 (parent strain) CJ0021 (mutant strain). L-alanine concentration (g / L) 5.98.4.
[0091] As a result, as shown in Table 2, it was confirmed that the Corynebacterium glutamicum CJ0021 strain with the introduced mutation produced L-alanine at a concentration of 8.4 g / L, having an L-productivity of approximately 142% compared to the parent strain.
[0092] The above results show that a mutation in which the 88th nucleotide C is substituted with T, the 90th nucleotide A is substituted with T, and the 91st nucleotide C is substituted with A in the sequence of the promoter region represented by SEQ ID NO: 2 significantly increases the L-alanine production ability of the microorganism. Therefore, a promoter in which the 88th nucleotide C is substituted with T, the 90th nucleotide A is substituted with T, and the 91st nucleotide C is substituted with A in the sequence of the promoter region represented by SEQ ID NO: 2 can be usefully utilized in a method for producing L-alanine.
[0093]
[0094] The composition of the medium used in Example 2 above is as follows.
[0095] Activation Badge
[0096] Beef extract 5 g / L, polypeptone 10 g / L, yeast extract 5 g / L, urea 2 g / L, sodium chloride (NaCl) 2.5 g / L, agar 20 g / L, glucose 10 g / L, 10N sodium hydroxide (NaOH) 100 ㎕ / L
[0097]
[0098] <Jongbaeji>
[0099] Glucose (anhydrous glucose) 20 g / L, polypeptone 10 g / L, yeast extract 10 g / L, ammonium sulfate [(NH4)2SO4] 10 g / L, urea 1.5 g / L, monobasic potassium phosphate (KH2PO4) 5.2 g / L, dibasic potassium phosphate (K2HPO4) 10.7 g / L, d-Biotin 1.8 mg / L, Thiamine-HCl 9 mg / L, CAPA 9 mg / L, NCA 60 mg / L, Magnesium sulfate (MgSO4) 0.5 g / L
[0100]
[0101] <Production medium>
[0102] Calcium carbonate (CaCO3) 30 g / L, sucrose 57 g / L, BM 6 g / L, magnesium sulfate (MgSO4) 0.5 g / L, (NH4)2SO4 50 g / L, KH2PO4 1 g / L, yeast extract 2 g / L, ammonium acetate 6.28 g / L, d-Biotin 0.05 mg / L, thiamine-HCl 0.1 mg / L, MnSO4 6.7 mg / L, FeSO4 10 mg / L
Claims
1. A polynucleotide in which the nucleotides corresponding to the 88th and 90th positions are each substituted with T, and the nucleotide corresponding to the 91st position is substituted with A, based on the nucleotide sequence represented by sequence number 2.
2. In the first paragraph, the polynucleotide is a polynucleotide consisting of a nucleotide sequence of sequence number 1.
3. A polynucleotide according to claim 1 or 2, wherein the polynucleotide has promoter activity.
4. A recombinant vector comprising the polynucleotide of claim 3; and a gene encoding a target protein operably linked to the polynucleotide.
5. A recombinant vector according to claim 4, wherein the target protein is an aminotransferase.
6. A microorganism of the genus Corynebacterium, comprising a polynucleotide of the third clause; and a gene encoding a target protein operably linked to the polynucleotide.
7. In the 6th paragraph, a microorganism of the genus Corynebacterium, wherein the polynucleotide consists of a nucleotide sequence of sequence number 1.
8. In paragraph 6, a microorganism of the genus Corynebacterium, wherein the target protein is an aminotransferase.
9. A Corynebacterium microorganism according to any one of claims 6 to 8, wherein the Corynebacterium microorganism is Corynebacterium glutamicum.
10. A method for producing an amino acid, comprising a step of culturing a microorganism of the genus Corynebacterium according to any one of claims 6 to 8 in a medium.
11. A method for producing an amino acid, wherein the amino acid in claim 10 is L-alanine.
12. A composition for producing amino acids comprising a microorganism of the genus Corynebacterium according to any one of claims 6 to 8.
13. A composition for producing an amino acid, wherein the amino acid in claim 12 is L-alanine.
